Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2012
08/22/2012CN102641397A Sheep placenta-containing composite capsule and preparation method thereof
08/22/2012CN102641380A Traditional Chinese medicine compound preparation for treating rhinitis and nasosinusitis and preparation process thereof
08/22/2012CN102641339A Chinese herbal medicine compound preparation for increasing body immunity and resisting fatigue
08/22/2012CN102641325A Health care product having function of resisting fatigue and enhancing immunity and preparation method thereof
08/22/2012CN102641307A Ganoderma lucidum granule and preparation method thereof
08/22/2012CN102641301A Preparation method for propolis solid dispersion
08/22/2012CN102641296A Preparation for inhibiting immunity and treating graft-versus-host diseases (GVHD) and preparation method of preparation
08/22/2012CN102641284A Application of spirulina platensis polysaccharide
08/22/2012CN102641279A Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
08/22/2012CN102641256A Preparation method for propolis micro-capsules
08/22/2012CN102641217A Application of interleukin-12 in facial beautifiers
08/22/2012CN102640918A Preparation method of ant, burdock and ganoderma lucidum liquid
08/22/2012CN102151283B Compound medicament for preventing and treating chicken diseases
08/22/2012CN102145022B Lucid ganoderma composition with effects of enhancing immunity and resisting radiation and preparation method thereof
08/22/2012CN102114067B Compound oviductus ranae granules and application thereof
08/22/2012CN102101893B Method for enriching and purifying aloe polysaccharides in aloe
08/22/2012CN102091317B Qi-tonifying desensitizer and use thereof
08/22/2012CN102078354B Medicine composition capable of improving immunity and preparation method thereof
08/22/2012CN102078339B Method for enriching and purifying common phellinus fungus general flavone in common phellinus fungus
08/22/2012CN102068434B Application of 4-(cyclohexyl)-aminoquinazoline compounds
08/22/2012CN102040667B Method for biologically removing protein from sea cucumber polysaccharide
08/22/2012CN102010460B Tea seed polypeptide and preparation method thereof
08/22/2012CN101967113B 3-alloc amido-3-(3- nitryl-4-fluorophenyl) propionic acid and preparation method thereof
08/22/2012CN101962349B 3-Boc amidocyanogen-3-(3-nitryl-4-fluorophenyl) monoprop and preparation method thereof
08/22/2012CN101948439B Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck
08/22/2012CN101711582B Composition containing American ginseng extract and probiotics and application thereof
08/22/2012CN101632704B Traditional Chinese medicine composition for resisting fatigue and improving immunity and preparation method thereof
08/22/2012CN101560246B Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs
08/22/2012CN101346346B Amine compound and use thereof for medical purposes
08/22/2012CN101166559B Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
08/21/2012US8247434 Fexofenadine polymorphs and processes of preparing the same
08/21/2012US8247424 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
08/21/2012US8247372 Depsipeptides and their therapeutic use
08/21/2012US8246987 Controlled release composition and method of producing the same
08/21/2012US8246958 Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
08/21/2012CA2639247C Methods of enhancing the quality, nutritive and health values of meat from bovine
08/21/2012CA2545427C Selective kinase inhibitors
08/21/2012CA2497351C Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
08/21/2012CA2495830C The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
08/21/2012CA2449284C Alpha-fetoprotein peptides and uses thereof
08/21/2012CA2425358C A vaccine composition comprising qs21, mpl, a cpg oligonucleotide and a cancer antigen
08/21/2012CA2398264C Use of desloratadine for treating allergic and inflammatory conditions
08/21/2012CA2337807C Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same
08/18/2012CA2768801A1 Generation of virus-like particles and use as panfilovirus vaccine
08/16/2012WO2012108960A2 Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
08/16/2012WO2012108827A1 Wheat antigens and peptides for diagnosis of wheat induced hypersensitivity
08/16/2012WO2012108347A1 Method for producing innate immunity activator having enhanced innate immunity promoting activity, and royal jelly-derived innate immunity activator which is produced by the production method
08/16/2012WO2012108195A1 Method for producing virus vector for gene transfer
08/16/2012WO2012107932A1 B cell clonal immunotoxin and use thereof
08/16/2012WO2012107769A1 Treatment of allergic disorders
08/16/2012WO2012107153A1 Amino statin derivativesfor the treatment of arthrosis
08/16/2012WO2012107095A1 Plant hsp70 for use in the treatment of food allergy
08/16/2012WO2012106995A1 Rorgammat inhibitors
08/16/2012WO2012084993A3 Biologically active oligonucleotides capable of modulating the immune system i
08/16/2012WO2012068441A3 Intedanib salts and solid state forms thereof
08/16/2012WO2012064981A3 Methods to test allergic conditions
08/16/2012WO2012053828A3 Human interleukin-1 receptor antagonist - hybrid fc fusion protein
08/16/2012WO2012012531A3 Compositions and methods featuring il-6 and il-21 antagonists
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120209012 Compounds, compositions and methods
08/16/2012US20120208889 Class- and isoform-specific hdac inhibitors and uses thereof
08/16/2012US20120208855 Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders
08/16/2012US20120208854 Therapeutic combination
08/16/2012US20120208840 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors
08/16/2012US20120208808 Pyrazolopyrimidine derivatives
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208801 Aminodiazepines as Toll-Like Receptor Modulators
08/16/2012US20120208800 Bromodomain Inhibitors For Treating Autoimmune And Inflammatory Diseases
08/16/2012US20120208798 Tetrahydroquinoline Derivatives And Their Pharmaceutical Use
08/16/2012US20120208793 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
08/16/2012US20120208785 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
08/16/2012US20120208774 Method for inhibiting "melanoma inhibitory activity" mia
08/16/2012US20120208772 Cytokine zalpha11 ligand
08/16/2012US20120208756 Composition for external preparation for skin
08/16/2012US20120208260 Novel lactobacillus plantarum and composition comprising the same
08/16/2012US20120207815 Method of treating eosinophilic esophagitis
08/16/2012US20120207799 Oral delivery vehicle and material
08/16/2012US20120207790 Immunosuppressing agent comprising mesenchymal stem cell derived from adipose tissue, and use thereof
08/16/2012US20120207789 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
08/16/2012US20120207788 Hypoallergenic hybrid polypeptides for the treatment of allergy
08/16/2012US20120207784 Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
08/16/2012US20120207783 Hiv vaccine formulations
08/16/2012US20120207780 Vaccine Composition
08/16/2012US20120207779 Anaplasma phagocytophilum (Aph) Antigens and Antibodies Specific for Anaplasma
08/16/2012US20120207777 Detoxified escherichia coli immunogens
08/16/2012US20120207776 Conserved escherichia coli immunogens
08/16/2012US20120207775 Immunogenic Epitopes as Targets for Universal Cancer Vaccines
08/16/2012US20120207773 Materials and methods for the development of an antigen-specific immune non-responsiveness state
08/16/2012US20120207766 Intracellular toll-like receptors pathways and axonal degeneration
08/16/2012US20120207765 Chemokine receptor antagonists and use thereof
08/16/2012US20120207759 Compositions and methods for modulating lymphocyte activity
08/16/2012US20120207754 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
08/16/2012US20120207752 Methods for modulating il-33 activity
08/16/2012US20120207746 Anti-C epsilon mX antibodies capable of binding to human mIgE on B Lymphocytes
08/16/2012US20120207737 Medical utility of glycan-binding proteins and glycans
08/16/2012US20120207727 Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207706 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
08/16/2012US20120207670 Method for Treating Psoriasis by Administering An Anti-IL-12 Antibody
08/16/2012CA2828059A1 Rorgammat inhibitors
1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 1172